Activity value 81International Buyer&Supplier,Last transaction date:
2026-07-08Address: suite 608, 6 f, devon house, taikoo,place, quarry bay, hong kong.,,
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for zuellig pharma pte.ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 631 transactions, with a transaction quantity of 683953.61 and a transaction weight of 787598.99.
YearTransactionsQuantityWeight
202511164271300.05608634.95
2026631683953.61787598.99
Bill of lading data
<
1/15
>
Trade date
2026/07/08
B/L No.
cosu6503159780
Suppliers
g production inc
Buyers
zuellig pharma pte.ltd.
POLs
12493, vancouver, bc
PODs
3001, seattle, wa
Supply area
Canada
Purchas area
United States
Weight
11885kg
Amount
——
Hs code
Product tags
cetaphil
Product description
CETAPHIL Expand
Trade date
2026/07/01
B/L No.
cosu6502043810
Suppliers
g production inc
Buyers
zuellig pharma pte.ltd.
Product description
1 VIAL LABELED 1X KIT OF MAA868/ABELACIMAB 150MG/ML VIALS OR PLACEBO TO MATCH FOR PROTOCOL ANT-010 (UOM VIAL) (GOODS FOR CLINICAL TRIAL USE ONLY) (150 MG/ 1ML VIAL SOLUTION FOR SUBCUTANEOUS INJECTION)
Expand
Product description
3 VIALS LABELED 1X KIT OF MAA868/ABELACIMAB 150MG/ML VIALS OR PLACEBO TO MATCH FOR PROTOCOL ANT-010 (UOM VIAL) (GOODS FOR CLINICAL TRIAL USE ONLY) (150 MG/ 1ML VIAL SOLUTION FOR SUBCUTANEOUS INJECTION)
Expand
Trade date
2026/06/29
B/L No.
15767568174
Suppliers
societe des produits nestle s.a.
Buyers
zuellig pharma pte.ltd.
Product description
2 VIALS LABELED 1X KIT OF MAA868/ABELACIMAB 150MG/ML VIALS OR PLACEBO TO MATCH FOR PROTOCOL ANT-010 (UOM VIAL) (GOODS FOR CLINICAL TRIAL USE ONLY) (150 MG/ 1ML VIAL SOLUTION FOR SUBCUTANEOUS INJECTION)
Expand
Product description
3 VIALS LABELED 1X KIT OF MAA868/ABELACIMAB 150MG/ML VIALS OR PLACEBO TO MATCH FOR PROTOCOL ANT-010 (UOM VIAL) (GOODS FOR CLINICAL TRIAL USE ONLY) (150 MG/ 1ML VIAL SOLUTION FOR SUBCUTANEOUS INJECTION)
Expand
Product description
4 VIALS LABELED 1X KIT OF MAA868/ABELACIMAB 150MG/ML VIALS OR PLACEBO TO MATCH FOR PROTOCOL ANT-010 (UOM VIAL) (GOODS FOR CLINICAL TRIAL USE ONLY) (150 MG/ 1ML VIAL SOLUTION FOR SUBCUTANEOUS INJECTION)
Expand
Product description
120 UNT (UNITS) DYSPORT 300U 1 VIAL PH BULK LOT NUMBER 033439 (300 IU FREEZE DRIED POWDER FOR SOLUTION FOR INJECTION (IM/SC)
Expand
5sandoz s.a.
indiabuyer,they trade on 2023-06-27
5820.85%
>
+View All
Products
Total 778
ProductsTransactionsPerDetail
bat 47828.23%>
ion 31418.55%>
sol 26515.65%>
for injection 24814.65%>
eye drop 1689.92%>
+View All
Hscode rank
Total 368
HSCode NameTransactionsPerDetail
HS 3004909900042925.34%>
HS 30021500000965.67%>
HS 30049099895.26%>
HS 9018399000865.08%>
HS 33049990000794.67%>
+View All
Trading Area
Total 36
AreaTransactionsPerDetail
costa rica33714.91%>
india18192.65%>
indonesia15002.18%>
singapore10001.46%>
philippines7261.06%>
+View All
Port statistics
Total 43
Port NameTransactionsPerDetail
hong kong9861.44%>
port kelang8581.25%>
ninoy aquino international airport8511.24%>
singapore5550.81%>
port of clark2480.36%>
+View All
zuellig pharma pte.ltd. is International Buyer&Supplier,
and primarily engages in the import and export business of products such as bat,ion,sol.
According to the 52wmb.com global trade database, as of 2026-07-08, the company has completed 68677 international trades,
with its main trading regions covering costa rica,india,indonesia etc.
The core products include HS30049099000,HS30021500000,HS30049099 etc,
often transported via hong kong,port port kelang, port ninoy aquino international airport etc,
and its main trading partners are eurofins central laboratory pte,p.t.bayer indonesia,reckitt benckiser malaysia sdn bh lot pvt ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on zuellig pharma pte.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.